Remember that GLP-1 receptor agonists should not be combined with DPP-4 inhibitors, as both work on the incretin system
Clinical signs that might suggest compromised medication include unexpected loss of appetite suppression, return of cravings, or weight loss plateau that cannot be explained by other factors such as dietary changes or increased caloric intake
Barzanti V, Battino M, Baracca A, Cavazzoni M, Cocchi M, Noble R, Maranesi M, Tur chetto E, Lenaz G: The effect of dietary lipid changes on the fatty acid composition and function of liver, heart and brain mitochondria in the rat at different ages
[DOI] [PubMed] [Google Scholar] 72.Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C, Zacharoulis D
A compelling body of circumstantial evidence suggests that IGF/IGF-1R and insulin/insulin receptor (IR) serve overlapping functions in selected tissues including the skeleton
visualization, S.M.B., K.P.S